LONDON, Feb. 14, 2017 /PRNewswire/ --
Global Molecular Diagnostics Market: Overview
This report onthe molecular diagnostics market studies the current and future prospects of the market globally. Growing incidences of chronic infectious diseases such as tuberculosis, HIV/AIDS, diarrhea, pneumonia hepatitis, in addition to increasing geriatric population,
Global Molecular Diagnostics Market: Segmentation
Based on technology, the molecular diagnostics market has been segmented into six major categories: PCR and real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing and others which includes mass spectrometry etc. These are the major techniques which are used in molecular diagnostics for diagnosis of disease. Likewise, on the basis of application, the global molecular diagnostics market has been segmented into infectious diseases, oncology, blood screening, microbiology, genetic testing and women's health. Infectious disease testing has been segmented into two major categories, namely, virology and bacteriology. The market segments have been extensively analyzed based on usefulness, adoption, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2015 to 2025. The molecular diagnostics market report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2015 as the base year. A brief patient pool analysis by infectious disease, cancer and cardiovascular disease have also been discussed in the global molecular diagnostics report.
Based on End User the global molecular diagnostics market is segmented as hospitals, diagnostic laboratories, blood banks, academics & research and others. The market size and forecast for each of these end user has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year.
Global Molecular Diagnostics Market: Regional Outlook
Geographically, the molecular diagnostics market in Europe has been categorized into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving that is supply side driver, demand side driver and economic driver, restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter's Five Forces analysis, and market share analysis by key players, competitive matrix thus presenting a thorough analysis of the overall competitive scenario in the global molecular diagnostics market.
Key Players Mentioned in this Report are:
Current and future trends has also been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the global molecular diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments, SWOT analysis. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V. ,bioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG and Thermo Fisher Scientific Inc., and others.
The global molecular diagnostics market is segmented as given below:
Global Molecular Diagnostics Market, by Technology
PCR and Real-Time PCRHybridizationMicroarrayTranscription-Mediated AmplificationNext-Generation SequencingOthers (Mass Spectrometry, etc.)
Global Molecular Diagnostics Market, by Application
Infectious DiseasesOncologyBlood ScreeningMicrobiologyGenetic TestingWomen's Health
Global Molecular Diagnostics Market, by End Use
HospitalsDiagnostic LaboratoriesBlood BanksAcademicsResearch
Global Molecular Diagnostics Market, by Region
North AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalySpainRest of EuropeAsia PacificChinaJapanAustraliaIndiaRest of Asia PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaSaudi ArabiaSouth AfricaRest of Middle East & Africa
Download the full report: https://www.reportbuyer.com/product/4698532/
About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/molecular-diagnostics-market---global-industry-analysis-size-share-growth-trends-and-forecast-2017---2025-300407344.html
Subscribe to our Free Newsletters!
Opportunistic infections are microbial infections that can cause disease in persons with a weak ...
The state health insurance programs provide health care support to the below poverty line (BPL) ...
There is a lining between the lungs and chest wall known as Pleura. The dismissal of pleura by a ...View All